Companies: 10,795·Total market cap: $144.5T
Astrana Health, Inc.

Astrana Health, Inc.

ASTHNASDAQHealthcare● Active
$38.08
+$0.09(+0.24%)
Market Cap$1.9B
P/E Ratio
52W High$39.93
52W Low$18.08
Overview

Astrana Health, Inc. (ASTH) Revenue

Annual & quarterly revenue history · segment & region breakdown

ASTH · revenue · updated Jun 8, 2026

Core revenue metrics

Astrana Health, Inc. trailing twelve-month (TTM) revenue is $3.53B, an increase of 56.39% year-over-year from $3.18B in FY2025.

TTM revenue
$3.53B
4-quarter sum · USD
YoY growth
+56.39%
vs FY2025 $3.18B
Price / sales
0.54×
mktCap ÷ TTM rev
Revenue per day
$10M
Est. TTM ÷ 365
Revenue / employee
$1856K
1900 employees
FY2025
$3.18B
FY2024
$2.03B
5Y CAGR
+32.7%
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Astrana Health, Inc. SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

20252016 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-12-31$3.18B+$1.15B+56.39%
2024-12-31$2.03B+$0.65B+46.72%
2023-12-31$1.39B+$0.24B+21.19%
2022-12-31$1.14B+$0.37B+47.84%
2021-12-31$0.77B+$0.40B+109.03%
2020-12-31$0.37B-$0.19B-33.96%
2019-12-31$0.56B+$0.04B+7.83%
2018-12-31$0.52B+$0.16B+45.33%
2017-12-31$0.36B+$0.31B+712.16%
2016-03-31$0.04B
ASTH revenue by year · ASTH revenue history · ASTH annual revenue data

Compare revenue vs peers

Medical - Care Facilities

Compare ASTH revenue against listed peers. Click any row to open that company's revenue tab.

Revenue breakdown

Segment & Geography
By business segment
Total$3.18B
$2.92B91.9%
$0.11B3.5%
$0.09B2.7%
$0.03B1.0%
$0.03B0.9%
By geography
No segment data available for this period.
Data from Astrana Health, Inc. annual 10-K filing · FY ending 2025-12-31
ASTH revenue breakdown · ASTH revenue by segment · ASTH revenue by region

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Astrana Health, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Astrana Health, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Astrana Health, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

ASTH revenue · 4 questions

ASTH's trailing twelve-month (TTM) revenue is $3.53B. That is an increase of 56.39% year-over-year from $3.18B in FY2025.

ASTH revenueASTH annual revenuewhat is ASTH revenueASTH TTM revenue

Source: FMP · Astrana Health, Inc. SEC filings · GAAP · Astrana Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026